Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.44% Nasdaq Down0.47%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS

12.38 Down 0.15(1.20%) 10:16AM EDT - Nasdaq Real Time Price

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.3
Mean Recommendation (last week):1.3
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:15.75
Median Target:15.50
High Target:20.00
Low Target:13.00
No. of Brokers:8

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Apr 3, 2012Cantor FitzgeraldInitiated Buy
May 16, 2011OppenheimerInitiated Outperform
Sep 30, 2010WedbushInitiated Outperform
Feb 24, 2010Roth CapitalInitiated Buy
Sep 28, 2009WBB SecuritiesInitiated Strong Buy
Dec 18, 2008NeedhamDowngradeBuyHold
Oct 23, 2008Merriman Curhan FordInitiated Buy
Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy6665
Buy2222
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.